Biohit Hefei's SARS-CoV-2 Antigen Rapid Test (Colloidal Gold Method) has been granted approval by the Therapeutic Goods Administration (TGA), The Australian Regulatory body for Therapeutic Devices, for laboratory and POC use in Australia.

https://www.tga.gov.au/covid-19-test-kits-included-artg-legal-supply-australia

Prior to this rapid test, Biohit (Hefei) already had SARS-CoV-2 IgM/IgG Antibody Test Kit (Colloidal Gold Method), SARS-CoV-2 Antigen Quantitative Assay Kit (Enzyme-linked Immunoassay) and SARS-CoV-2 Antigen Rapid Test Kit  (Fluorescence Immunochromatography) approved by TGA.